Juiwanna Kushner

1.6k citations

31 papers · 1.1k indexed · h-index 22

Co-authors: Kathryn White Lisa Polin Thomas H. Corbett Jerome P. Horwitz Stuart Hazeldine Larry H. Matherly Aleem Gangjee Zhanjun Hou
Topics: Folate and B Vitamins Research (10 papers)Cancer therapeutics and mechanisms (9 papers)Biochemical and Molecular Research (8 papers)
Cited by: Hematology Rheumatology Organic Chemistry
Journals: Blood Clinical Cancer Research Journal of Medicinal Chemistry
Partner nations: United States China Italy

In The Last Decade

Juiwanna Kushner

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Juiwanna Kushner

Since Specialization

Citations

This map shows the geographic impact of Juiwanna Kushner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juiwanna Kushner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juiwanna Kushner more than expected).

Fields of papers citing papers by Juiwanna Kushner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juiwanna Kushner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juiwanna Kushner. The network helps show where Juiwanna Kushner may publish in the future.

Co-authorship network of co-authors of Juiwanna Kushner

This figure shows the co-authorship network connecting the top 25 collaborators of Juiwanna Kushner. A scholar is included among the top collaborators of Juiwanna Kushner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juiwanna Kushner. Juiwanna Kushner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress 2025 ·Journal of Experimental & Clinical Cancer Research ·Jenna L. Carter,Yongwei Su,(unknown),Jianlei Zhao,(unknown),Guan Wang,Holly Edwards,Lisa Polin,Juiwanna Kushner,(unknown),Kathryn White,Steven Buck,Maik Hüttemann,Joshua E. Allen,(unknown),Jay Yang,Jeffrey W. Taub,Yubin Ge	0
2	The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML 2021 ·Blood Cancer Journal ·(unknown),Jun Ma,Tristan Knight,Yongwei Su,Holly Edwards,Lisa Polin,Jing Li,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Jian Wang,Hai Lin,Yue Wang,(unknown),Guan Wang,Jeffrey W. Taub,Yubin Ge	27
3	Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia 2020 ·Signal Transduction and Targeted Therapy ·Daniel A Luedtke,Yongwei Su,Jun Ma,Xinyu Li,Steven Buck,Holly Edwards,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Hai Lin,Jeffrey W. Taub,Yubin Ge	50
4	Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation 2020 ·Cancers ·Fangbing Liu,Hasini A. Kalpage,(unknown),Holly Edwards,Maik Hüttemann,Jun Ma,Yongwei Su,Jenna L. Carter,Xinyu Li,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Guan Wang,Jeffrey W. Taub,Yubin Ge	29
5	The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia 2020 ·Haematologica ·Xinyu Li,Yongwei Su,(unknown),Gerard J. Madlambayan,Holly Edwards,Tristan Knight,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Jay Yang,(unknown),Guan Wang,Lijing Zhao,Y. Lynn Wang,(unknown),Jeffrey W. Taub,Yubin Ge	38
6	Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Jun Ma,(unknown),(unknown),Tristan Knight,Holly Edwards,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Guan Wang,Lijing Zhao,Hai Lin,Yue Wang,Jeffrey W. Taub,Yubin Ge	117
7	Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates 2017 ·Molecular Cancer Therapeutics ·Zhanjun Hou,(unknown),(unknown),Yang Si,Adrianne Wallace-Povirk,(unknown),(unknown),Lisa Polin,Kathryn White,Juiwanna Kushner,Robert Morris,Aleem Gangjee,Larry H. Matherly	38
8	Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates 2016 ·Molecular Pharmacology ·Mike R. Wilson,Zhanjun Hou,Si Yang,Lisa Polin,Juiwanna Kushner,Kathryn White,(unknown),Manohar Ratnam,Aleem Gangjee,Larry H. Matherly	20
9	6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors 2015 ·Journal of Medicinal Chemistry ·Lei Wang,Adrianne Wallace-Povirk,Sudhir Raghavan,(unknown),Mike R. Wilson,Si Yang,Lisa Polin,Kathryn White,Juiwanna Kushner,(unknown),(unknown),(unknown),Zhanjun Hou,(unknown),Charles E. Dann,Larry H. Matherly,Aleem Gangjee	35
10	Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter 2013 ·Cancer Chemotherapy and Pharmacology ·Christina Cherian,Sita Kugel Desmoulin,Lei Wang,Lisa Polin,Kathryn White,Juiwanna Kushner,Mark Stout,Zhanjun Hou,Aleem Gangjee,Larry H. Matherly	20
11	Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter 2012 ·Molecular Pharmacology ·Sita Kugel Desmoulin,Lei Wang,Lisa Polin,Kathryn White,Juiwanna Kushner,Mark Stout,Zhanjun Hou,Christina Cherian,Aleem Gangjee,Larry H. Matherly	27
12	Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter 2011 ·Molecular Pharmacology ·Sita Kugel Desmoulin,Lei Wang,(unknown),Lisa Polin,Kathryn White,Juiwanna Kushner,Mark Stout,Zhanjun Hou,Christina Cherian,Aleem Gangjee,Larry H. Matherly	57
13	Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4 2005 ·Bioorganic & Medicinal Chemistry ·Stuart Hazeldine,Lisa Polin,Juiwanna Kushner,Kathryn White,Thomas H. Corbett,Jerome P. Horwitz	22
14	Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5 2005 ·Bioorganic & Medicinal Chemistry ·Stuart Hazeldine,Lisa Polin,Juiwanna Kushner,Kathryn White,Thomas H. Corbett,Jerome P. Horwitz	21
15	Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid 2004 ·Bioorganic & Medicinal Chemistry ·Stuart Hazeldine,Lisa Polin,Juiwanna Kushner,Kathryn White,Thomas H. Corbett,(unknown),Jerome P. Horwitz	54
16	Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors 2003 ·Cancer Chemotherapy and Pharmacology ·Ramesh Boinpally,Lisa Polin,Sen-Lin Zhou,Bhaskara Jasti,Richard Wiegand,Kathryn White,Juiwanna Kushner,Jerome P. Horwitz,Thomas H. Corbett,Ralph E. Parchment	6
17	Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169 2003 ·Investigational New Drugs ·Thomas H. Corbett,Kathryn White,Lisa Polin,Juiwanna Kushner,(unknown),Chuan Shih,(unknown)	23
18	Preclinical Efficacy Evaluations of XK-469: Dose Schedule, Route and Cross-Resistance Behavior in Tumor Bearing Mice 2002 ·Investigational New Drugs ·Lisa Polin,Kathryn White,Juiwanna Kushner,(unknown),(unknown),Susan Pugh,(unknown),Stuart Hazeldine,Joseph A. Fontana,Patricia LoRusso,Jerome P. Horwitz,Thomas H. Corbett	13
19	Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate 1998 ·Investigational New Drugs ·Thomas H. Corbett,Patricia LoRusso,(unknown),(unknown),Susan Pugh,Kathryn White,Juiwanna Kushner,Lisa Polin,Jennifer Meyer,(unknown),Lance K. Heilbrun,Jerome P. Horwitz,Janet L. Gross,Carl H. Behrens,Barbara Harrison,R. J. McRipley,George L. Trainor	55
20	Discovery of cryptophycin-1 and BCN-183577: Examples of strategies and problems in the detection of antitumor activity in mice 1997 ·Investigational New Drugs ·Thomas H. Corbett,Frederick A. Valeriote,Lisa Demchik,(unknown),Lisa Polin,(unknown),Susan Pugh,Kathryn White,Juiwanna Kushner,James Rake,Mark P. Wentland,Trimurtulu Golakoti,(unknown),(unknown),Gregory M. L. Patterson,Richard E. Moore	39

About Juiwanna Kushner

Juiwanna Kushner is a scholar working on Rheumatology, Hematology and Molecular Biology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (10 papers), Cancer therapeutics and mechanisms (9 papers) and Biochemical and Molecular Research (8 papers). The work is most often cited by research in Hematology (228 citations), Rheumatology (242 citations) and Organic Chemistry (389 citations). Juiwanna Kushner has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Kathryn White, Lisa Polin, Thomas H. Corbett, Jerome P. Horwitz, Stuart Hazeldine, Larry H. Matherly, Aleem Gangjee, Zhanjun Hou, Sijana H. Dzinic and Jeffrey W. Taub. Their work appears in journals such as Blood, Clinical Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact